A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician s Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy, of Which at Least One Line Must Be Systemic Therapy

IRB/UVA Tracking #
21271
Contact
Olusegun Adelaja
Contact Phone
Phase
III
Primary purpose
Treatment
Cancer PI
Varinder Kaur
Status
OPEN TO ACCRUAL
Ages
Adult